Semaglutide Dosing: FDA-Label Ranges and Titration

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

For a plain-language primer, visit the PlexusDx Education Hub before you dig into label details.

Questions about semaglutide dosing deserve a careful answer, because the useful information here is what the FDA label documents, not a personal schedule. This page reports the label-level facts, what doses exist and how titration works as a concept, while leaving every individual decision to a qualified prescriber.

What the FDA label documents

Per the semaglutide FDA label, ranges depend on formulation: 0.25 to 2.4 mg per week subcutaneous under the Wegovy and Ozempic labels, or 3 to 14 mg daily oral under the Rybelsus label. Semaglutide is available as a once-weekly subcutaneous injection or a once-daily oral tablet. The label describes a graduated titration concept, beginning at the lowest dose so the body can adapt to GLP-1 pathway activation, then increasing under prescriber supervision based on tolerability and response.

Why titration is built into the label

Slow titration is the standard clinical approach across the GLP-1 class because gastrointestinal side effects, nausea in particular, are most pronounced during dose escalation. The label titration concept is designed to reduce intolerable symptoms while maintaining therapeutic momentum. Real-world data associate skipped or accelerated titration with higher discontinuation rates, which is why the graduated structure exists.

Format matters as much as amount

Because semaglutide comes as both a weekly injection and a daily oral tablet, dosing is not a single scale. The subcutaneous and oral forms have different ranges and different administration details in their labels and patient information leaflets. That is one reason a number seen for one format does not transfer to another; the format frames the dosing conversation.

What belongs in a provider conversation

Dose selection, titration speed, and any adjustments are individualized clinical decisions. Providers typically weigh baseline metabolic status, kidney function, gastrointestinal history, prior medication tolerability, and the FDA-approved indication on the prescription. The consistent message across the class is simple: never adjust GLP-1 receptor agonist dosing on your own. PlexusDx offers semaglutide within its Weight Management Protocols, including Semaglutide Injection and Semaglutide Oral.

Genetics as upstream context

Dosing lives with your prescriber; your baseline biology is worth understanding first. The Precision Peptide Genetic Test maps 14 pathways, 49 peptides, 150+ genetic insights, including variants in GLP1R, FTO, and MC4R that shape appetite and energy balance. It does not predict dose response or titration tolerability; it is trait context for a broader provider conversation.

Reading label facts responsibly

There is a difference between knowing what a label documents and knowing what to do, and this page deliberately stays on the first side of that line. Reporting that a range exists, or that titration starts low and increases, is educational context. Translating any of it into a personal schedule is a clinical act that belongs to a prescriber who knows your history.

That distinction is not a technicality. Because tolerability, kidney function, and prior medication experience all shape the right approach, the same label facts can lead to different individual plans. Understanding the label helps you ask sharper questions; it does not replace the person authorized to answer them for you.

The bottom line on dosing

The useful, safe knowledge here is what the FDA label documents: defined ranges by formulation and a graduated titration concept that starts low and increases under supervision. Translating any of it into a personal schedule is a clinical act for your prescriber, who weighs tolerability, kidney function, and history. Understanding the label lets you ask sharper questions and recognize why titration exists, while leaving the decisions to the professional authorized to make them for you. A little preparation on your part, paired with your prescriber's ongoing oversight, is what turns published label facts into a plan that genuinely fits your circumstances and history.

The bottom line on dosing

The useful, safe knowledge here is what the FDA label documents: defined ranges by formulation and a graduated titration concept that starts low and increases under supervision. Translating any of it into a personal schedule is a clinical act for your prescriber, who weighs tolerability, kidney function, and history. Understanding the label lets you ask better questions and recognize why titration exists, while leaving the decisions to the professional authorized to make them for you.

Frequently Asked Questions

What dosing does the FDA label describe?

Per the label, ranges depend on formulation: 0.25 to 2.4 mg per week subcutaneous under the Wegovy and Ozempic labels, or 3 to 14 mg daily oral under the Rybelsus label. The label sets a graduated titration approach. Specific dose selection and titration speed are individualized decisions your prescriber makes; never adjust dosing yourself.

How is semaglutide administered?

Semaglutide is available as a once-weekly subcutaneous injection or a once-daily oral tablet. The complete administration protocol, including timing, storage, and any technique guidance, appears in the FDA label and the patient information leaflet that ships with the medication. Your prescriber and pharmacist will walk you through the specifics for your format.

Why does semaglutide use a titration schedule?

Titration reduces gastrointestinal side effects such as nausea, vomiting, and diarrhea that are most pronounced during dose escalation. The graduated schedule lets the body adapt to GLP-1 pathway activation and improves tolerability. Real-world data link skipped titration to higher discontinuation rates, which is why the stepwise approach is standard across the class.

Can genetics guide my dose?

No. The Precision Peptide Genetic Test does not predict semaglutide dose response or titration tolerability. It analyzes pathway variants in genes such as GLP1R, FTO, and MC4R that shape baseline GLP-1 biology, offering context for the broader protocol conversation with a provider rather than a dose-selection tool.

Explore more at the Education Hub.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.